Hospital de La Santa Creu I Sant Pau
Barcelona, BARCELONA, 08025, Spain
NCT Number: NCT07530237
This retrospective observational study evaluates the efficacy of periarticular vasoconstrictor infiltration (PVI) in reducing intraoperative bleeding and postoperative pain in adult patients undergoing lumbar fusion surgery at Hospital de la Santa Creu i Sant Pau (Barcelona, Spain) from November 2024 to October 2025. PVI, introduced recently as an alternative to erector spinae plane (ESP) block, involves ultrasound-guided infiltration of local anesthetic with epinephrine in deep and superficial periarticular planes before surgery. The study includes all consecutive cases meeting inclusion criteria (lumbar fusion in adults), excluding incomplete records (expected n=25).
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Barcelona, BARCELONA, 08025, Spain
Lumbar fusion surgery treats degenerative disc disease, spondylolisthesis, and lumbar stenosis when conservative management fails. It carries high risks of intraoperative bleeding (often requiring transfusion) and severe postoperative pain necessitating systemic opioids, impacting patient safety and recovery. Multimodal pain management and bleeding control are key challenges. Periarticular vasoconstrictor infiltration (PVI), inspired by tumescent anesthesia and WALANT techniques, has shown promise in reducing bleeding and improving analgesia in other orthopedic procedures. At Hospital de la Santa Creu i Sant Pau (Barcelona, Spain), PVI-ultrasound-guided infiltration of local anesthetic with epinephrine in deep/superficial periarticular planes was recently adopted preoperatively, replacing erector spinae plane (ESP) block, with promising clinical outcomes lacking formal retrospective analysis
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasound-guided infiltration of local anesthetic and epinephrine in deep and superficial periarticular planes before lumbar fusion surgery, as part of routine clinical care.
Time frame: Perioperative
Total volume aspirated (mL) from surgical suction, minus irrigation volume
Time frame: up to 24 hours
Numeric Verbal Scale (0-10) at 24 hours
Time frame: up to 24 hours
Total systemic opioid dose administered postoperatively
Time frame: up to 24 hours
Incidence of nausea, vomiting, constipation, or sedation related to postoperative opioid use
Time frame: Perioperative
Total postoperative drain output (mL) recorded in surgical drains
Time frame: Perioperative
Proportion of patients requiring perioperative red blood cell transfusion
Time frame: Perioperative
Number of days from surgery to hospital discharge
Time frame: Perioperarive
Incidence of complications related to PVI or surgery (e.g., hypertension, arrhythmias, wound infection, hematoma, reoperation)
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Other
Efficacy of Periarticular Vasoconstrictor Infiltration (PVI) in Reducing Bleeding and Postoperative Pain in Lumbar Fusion Surgery: Retrospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05854537
Hemorrhage, Neurologic Manifestations
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT05986942
Anxiety, Anxiety Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07257757
Behavior, Health Behavior
Kirikkale, Turkey (Türkiye)
View Trial DetailsNCT07145879
Hemorrhage, Local Analgesia Via Infiltration
Denizli, Turkey (Türkiye)
View Trial Details